Literature DB >> 19705120

Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.

Hideki Nakamura1, Akitomo Okada, Atsushi Kawakami, Satoshi Yamasaki, Hiroaki Ida, Masakatsu Motomura, Daisuke Imanishi, Katsumi Eguchi.   

Abstract

A 47-year-old woman who had been treated for systemic lupus erythematosus (SLE) with myasthenia gravis (MG) was admitted to our hospital with acute onset of severe anemia after administration of isoniazid. Pure red cell aplasia (PRCA) was confirmed by elevated serum iron levels, reticulocytopenia and bone marrow aspiration showing a remarkable reduction of erythroblasts. Finally, cyclosporine A successfully improved PRCA. Although both SLE and MG have the potential complication of PRCA, we report here a case of isoniazid-triggered PRCA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705120     DOI: 10.1007/s00296-009-1113-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

Review 1.  Pure red cell aplasia and myasthenia gravis with thymoma: a case report and review of the literature.

Authors:  S Mizobuchi; T Yamashiro; Y Nonami; A Yamamoto; M Kume; H Nakaya; T Sawada; H Taguchi; T Moriki; S Ogoshi
Journal:  Jpn J Clin Oncol       Date:  1998-11       Impact factor: 3.019

Review 2.  Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure.

Authors:  Lay-Cheng Lim
Journal:  Hematology       Date:  2005-06       Impact factor: 2.269

3.  Pure red cell hypoplasia secondary to isoniazid.

Authors:  C R Lewis; A Manoharan
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

Review 4.  Pure red-cell aplasia: a review.

Authors:  A J Erslev; A Soltan
Journal:  Blood Rev       Date:  1996-03       Impact factor: 8.250

Review 5.  Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.

Authors:  Nicole Casadevall; Denis Cournoyer; Judith Marsh; Hans Messner; Chris Pallister; John Parker-Williams; Jérôme Rossert
Journal:  Eur J Haematol       Date:  2004-12       Impact factor: 2.997

Review 6.  Pure red cell aplasia and lupus.

Authors:  George S Habib; Walid R Saliba; Paul Froom
Journal:  Semin Arthritis Rheum       Date:  2002-02       Impact factor: 5.532

Review 7.  Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.

Authors:  Ting-Bo Liang; Dong-Lin Li; Jun Yu; Xue-Li Bai; Liang Liang; Shi-Guo Xu; Wei-Lin Wang; Yan Shen; Min Zhang; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

Review 8.  Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A.

Authors:  F Atzeni; P Sarzi-Puttini; F Capsoni; L Vulpio; M Carrabba
Journal:  Clin Exp Rheumatol       Date:  2003 Nov-Dec       Impact factor: 4.473

9.  Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.

Authors:  Ken-ichi Sawada; Makoto Hirokawa; Naohito Fujishima; Masanao Teramura; Masami Bessho; Kazuo Dan; Hisashi Tsurumi; Shinji Nakao; Akio Urabe; Mitsuhiro Omine; Keiya Ozawa
Journal:  Haematologica       Date:  2007-07-20       Impact factor: 9.941

10.  Diphenylhydantoin-induced pure red cell aplasia.

Authors:  E N Dessypris; S Redline; J W Harris; S B Krantz
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

View more
  2 in total

Review 1.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

2.  Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature.

Authors:  Yasuyuki Saito; Yuri Sawada; Yasuhiko Koga; Noriaki Sunaga; Yusuke Tsukagoshi; Yoshimasa Hachisu; Takashi Osaki; Reiko Sakurai; Kyoichi Kaira; Akihiro Ono; Ken Sato; Hiromi Koiso; Tetsunari Oyama; Takeshi Hisada; Masanobu Yamada
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.